Nuvation Bio (NUVB) Capital Expenditures (2020 - 2026)
Nuvation Bio (NUVB) recorded Capital Expenditures of $254,000 in Q2 2026, up 40.3% from $181,000 a year earlier and up 429.2% from the prior quarter.
Powered by 
Analysis
Nuvation Bio (NUVB) Capital Expenditures (2020 - 2026) Analysis & Trends
On a TTM basis, Nuvation Bio's Capital Expenditures came in at $8.05 million as of Jun 30, 2026; for FY2025, it was $8 million.
- Annual Capital Expenditures has a five-year compound annual growth rate of 123.0% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $162,000 in FY2024 (+134.8%), $69,000 in FY2023 (-81.4%), $370,000 in FY2022 (+31.2%) and $282,000 in FY2021 (+94.5%).
- Quarterly Capital Expenditures has ranged from -$13,000 in Q4 2024 to $7.75 million in Q3 2025 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in three of the last four quarters, with growth averaging 186.6%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 572.7% in Q3 2024, against a decline of 93.9% in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Nuvation Bio | 1.94 Bn | 1.94 Bn | - | 254,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 254,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 148,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 114,000.00 |
API Access
Nuvation Bio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NUVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NUVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NUVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();